• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种利用小檗胺(一种植物生物碱)的培养方法通过调节细胞代谢来增强 CAR-T 细胞的疗效。

A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating cellular metabolism.

机构信息

Kirin Central Research Institute, Kirin Holdings Company, Ltd., 26-1, Muraoka-Higashi 2, Fujisawa, Kanagawa, 251-8555, Japan.

Shin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

出版信息

Commun Biol. 2024 Jun 4;7(1):685. doi: 10.1038/s42003-024-06297-0.

DOI:10.1038/s42003-024-06297-0
PMID:38834758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11150386/
Abstract

Memory T cells demonstrate superior in vivo persistence and antitumor efficacy. However, methods for manufacturing less differentiated T cells are not yet well-established. Here, we show that producing chimeric antigen receptor (CAR)-T cells using berbamine (BBM), a natural compound found in the Chinese herbal medicine Berberis amurensis, enhances the antitumor efficacy of CAR-T cells. BBM is identified through cell-based screening of chemical compounds using induced pluripotent stem cell-derived T cells, leading to improved viability with a memory T cell phenotype. Transcriptomics and metabolomics using stem cell memory T cells reveal that BBM broadly enhances lipid metabolism. Furthermore, the addition of BBM downregulates the phosphorylation of p38 mitogen-activated protein kinase and enhanced mitochondrial respiration. CD19-CAR-T cells cultured with BBM also extend the survival of leukaemia mouse models due to their superior in vivo persistence. This technology offers a straightforward approach to enhancing the antitumor efficacy of CAR-T cells.

摘要

记忆 T 细胞表现出优异的体内持久性和抗肿瘤功效。然而,制造分化程度较低的 T 细胞的方法尚未得到很好的建立。在这里,我们展示了使用小檗胺(BBM)制造嵌合抗原受体(CAR)-T 细胞,小檗胺是一种天然化合物,存在于中药小檗属植物中,可以增强 CAR-T 细胞的抗肿瘤功效。BBM 是通过使用诱导多能干细胞衍生的 T 细胞进行基于细胞的化合物筛选而鉴定的,从而提高了具有记忆 T 细胞表型的细胞活力。使用干细胞记忆 T 细胞进行的转录组学和代谢组学研究表明,BBM 广泛增强了脂质代谢。此外,添加 BBM 会下调 p38 丝裂原活化蛋白激酶的磷酸化,并增强线粒体呼吸。与 BBM 一起培养的 CD19-CAR-T 细胞还由于其优异的体内持久性而延长了白血病小鼠模型的存活时间。这项技术为增强 CAR-T 细胞的抗肿瘤功效提供了一种简单直接的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/d98cc80bc4d7/42003_2024_6297_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/cc4faa4f5273/42003_2024_6297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/ae6621c2fc36/42003_2024_6297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/fdc57a5df03e/42003_2024_6297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/26e3a83f6685/42003_2024_6297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/a6bd77b2a787/42003_2024_6297_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/30f87b1c2dda/42003_2024_6297_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/d98cc80bc4d7/42003_2024_6297_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/cc4faa4f5273/42003_2024_6297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/ae6621c2fc36/42003_2024_6297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/fdc57a5df03e/42003_2024_6297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/26e3a83f6685/42003_2024_6297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/a6bd77b2a787/42003_2024_6297_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/30f87b1c2dda/42003_2024_6297_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe66/11150386/d98cc80bc4d7/42003_2024_6297_Fig7_HTML.jpg

相似文献

1
A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating cellular metabolism.一种利用小檗胺(一种植物生物碱)的培养方法通过调节细胞代谢来增强 CAR-T 细胞的疗效。
Commun Biol. 2024 Jun 4;7(1):685. doi: 10.1038/s42003-024-06297-0.
2
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.在人血小板裂解物中扩增 CAR T 细胞可使 T 细胞具有体内长期存活能力。
J Immunother Cancer. 2019 Nov 28;7(1):330. doi: 10.1186/s40425-019-0804-9.
3
Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic Function.转座子介导的源自 CD45RA 阳性外周血单个核细胞的嵌合抗原受体 T 细胞具有强大且持久的抗白血病功能。
Front Immunol. 2022 Jan 27;13:770132. doi: 10.3389/fimmu.2022.770132. eCollection 2022.
4
Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T.胎盘循环 T 细胞:与成人 PBMC 来源的 CAR-T 相比,新型同种异体 CAR-T 细胞平台具有保留的 T 细胞干性、更有利的细胞因子谱和持久的疗效。
J Immunother Cancer. 2024 Apr 29;12(4):e008656. doi: 10.1136/jitc-2023-008656.
5
Improved CAR internalization and recycling through transmembrane domain optimization reduces CAR-T cytokine release and exhaustion.通过跨膜结构域优化改善嵌合抗原受体(CAR)的内化和再循环可减少CAR-T细胞因子释放和耗竭。
Front Immunol. 2025 Mar 27;16:1531344. doi: 10.3389/fimmu.2025.1531344. eCollection 2025.
6
Sodium citrate pretreatment enhances CAR-T cell persistence and anti-tumor efficacy through inhibition of calcium signaling.柠檬酸钠预处理通过抑制钙信号增强CAR-T细胞持久性和抗肿瘤疗效。
Front Immunol. 2025 Mar 17;16:1540754. doi: 10.3389/fimmu.2025.1540754. eCollection 2025.
7
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.诱导多能干细胞衍生的抗 GPC3 嵌合抗原受体表达的自然杀伤/固有淋巴细胞的非临床疗效、安全性和稳定的临床细胞处理。
Cancer Sci. 2020 May;111(5):1478-1490. doi: 10.1111/cas.14374. Epub 2020 Mar 31.
8
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma.自动化制造自体 CD19 CAR-T 细胞治疗非霍奇金淋巴瘤。
Front Immunol. 2020 Aug 7;11:1941. doi: 10.3389/fimmu.2020.01941. eCollection 2020.
9
GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy.GLUT1 过表达增强了 CAR T 细胞的代谢适应性和抗肿瘤疗效。
Mol Ther. 2024 Jul 3;32(7):2393-2405. doi: 10.1016/j.ymthe.2024.05.006. Epub 2024 May 7.
10
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.优化针对 IL13Rα2 的嵌合抗原受体 T 细胞,以提高对神经胶质瘤的抗肿瘤疗效。
Mol Ther. 2018 Jan 3;26(1):31-44. doi: 10.1016/j.ymthe.2017.10.002. Epub 2017 Oct 5.

引用本文的文献

1
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors.利用小分子抑制剂加速嵌合抗原受体T细胞(CAR-T)疗法
BioDrugs. 2025 Jan;39(1):33-51. doi: 10.1007/s40259-024-00688-9. Epub 2024 Nov 26.

本文引用的文献

1
Long-term outcomes following CAR T cell therapy: what we know so far.嵌合抗原受体 T 细胞疗法治疗后的长期结果:目前我们所了解的情况。
Nat Rev Clin Oncol. 2023 Jun;20(6):359-371. doi: 10.1038/s41571-023-00754-1. Epub 2023 Apr 13.
2
Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy.通过多能性重编程生成高增殖、年轻化的细胞毒性 T 细胞克隆,用于过继免疫治疗。
Mol Ther. 2021 Oct 6;29(10):3027-3041. doi: 10.1016/j.ymthe.2021.05.016. Epub 2021 May 21.
3
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
从 iPS 细胞中生成 T 细胞的一种临床适用且可扩展的方法,用于现成的 T 细胞免疫疗法。
Nat Commun. 2021 Jan 18;12(1):430. doi: 10.1038/s41467-020-20658-3.
4
MEK inhibition reprograms CD8 T lymphocytes into memory stem cells with potent antitumor effects.MEK 抑制将 CD8 T 淋巴细胞重编程为具有强大抗肿瘤作用的记忆干细胞。
Nat Immunol. 2021 Jan;22(1):53-66. doi: 10.1038/s41590-020-00818-9. Epub 2020 Nov 23.
5
Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells.小檗胺(BBM),一种天然的信号转导和转录激活因子3(STAT3)抑制剂,可协同增强索拉非尼对肝癌细胞的抗增殖和促凋亡作用。
ACS Omega. 2020 Sep 18;5(38):24838-24847. doi: 10.1021/acsomega.0c03527. eCollection 2020 Sep 29.
6
Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells.线粒体备用呼吸能力:非转化细胞和癌细胞中的机制、调节及其意义。
FASEB J. 2020 Oct;34(10):13106-13124. doi: 10.1096/fj.202000767R. Epub 2020 Aug 17.
7
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.多表型 CRISPR-Cas9 筛选鉴定 p38 激酶为过继免疫疗法的靶点。
Cancer Cell. 2020 Jun 8;37(6):818-833.e9. doi: 10.1016/j.ccell.2020.05.004.
8
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer.丝裂原活化蛋白激酶抑制剂与癌症中的T细胞依赖性免疫疗法
Pharmaceuticals (Basel). 2020 Jan 7;13(1):9. doi: 10.3390/ph13010009.
9
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy.优化嵌合抗原受体 T 细胞的制造方案以提高抗癌免疫治疗效果。
Int J Mol Sci. 2019 Dec 10;20(24):6223. doi: 10.3390/ijms20246223.
10
Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies.CD19 CAR T 细胞疗法治疗急性淋巴细胞白血病后复发的机制及其预防和治疗策略。
Front Immunol. 2019 Nov 12;10:2664. doi: 10.3389/fimmu.2019.02664. eCollection 2019.